Nabla
nabla.bioMaking drug development a true design discipline
Health & Wellnessdrug-discoverygenerative-aibiotechpharmaceuticalde-novo-designwet-labai-tools
About
Nabla is a biotech company that combines generative AI drug design with large-scale, human-relevant wet and dry lab testing to make drug discovery more precise and reliable. Their integrated platform owns the data, AI, and lab systems as a single engine to design medicines with the properties patients need. They partner with leading pharmaceutical companies to bring these designed drugs to market.
Problem
Drug development relies heavily on trial-and-error, making it slow, costly, and uncertain for getting effective medicines to patients.
For
pharmaceutical companies and drug developers
How it works
Nabla combines generative de novo drug design with large-scale human-relevant testing and integrated dry/wet-lab systems into one engine to turn discovery into a designable, engineerable process.
Business model
unknown
Status
launched
Company
Nabla